DE60040617D1 - Transgene maus, die steroid-aktivierte kernrezeptoren exprimiert - Google Patents
Transgene maus, die steroid-aktivierte kernrezeptoren exprimiertInfo
- Publication number
- DE60040617D1 DE60040617D1 DE60040617T DE60040617T DE60040617D1 DE 60040617 D1 DE60040617 D1 DE 60040617D1 DE 60040617 T DE60040617 T DE 60040617T DE 60040617 T DE60040617 T DE 60040617T DE 60040617 D1 DE60040617 D1 DE 60040617D1
- Authority
- DE
- Germany
- Prior art keywords
- sxr
- steroid
- steroids
- receptors
- response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000011830 transgenic mouse model Methods 0.000 title 1
- 102000000804 Pregnane X Receptor Human genes 0.000 abstract 6
- 108010001511 Pregnane X Receptor Proteins 0.000 abstract 6
- 150000003431 steroids Chemical class 0.000 abstract 4
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 230000004060 metabolic process Effects 0.000 abstract 2
- 102000006255 nuclear receptors Human genes 0.000 abstract 2
- 108020004017 nuclear receptors Proteins 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 abstract 1
- 206010013710 Drug interaction Diseases 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 abstract 1
- 101150053185 P450 gene Proteins 0.000 abstract 1
- 108091027981 Response element Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000833 heterodimer Substances 0.000 abstract 1
- 230000013632 homeostatic process Effects 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000037353 metabolic pathway Effects 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
- 239000002676 xenobiotic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Biodiversity & Conservation Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- High Energy & Nuclear Physics (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/458,366 US6984773B1 (en) | 1998-01-09 | 1999-12-09 | Transgenic mice expressing a human SXR receptor polypeptide |
PCT/US2000/033473 WO2001042290A2 (en) | 1999-12-09 | 2000-12-08 | Novel steroid-activated nuclear receptors and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60040617D1 true DE60040617D1 (de) | 2008-12-04 |
Family
ID=23820506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60040617T Expired - Lifetime DE60040617D1 (de) | 1999-12-09 | 2000-12-08 | Transgene maus, die steroid-aktivierte kernrezeptoren exprimiert |
Country Status (8)
Country | Link |
---|---|
US (3) | US6984773B1 (de) |
EP (2) | EP1235861B1 (de) |
JP (1) | JP2003516135A (de) |
AT (1) | ATE412011T1 (de) |
AU (1) | AU783367B2 (de) |
CA (1) | CA2394970C (de) |
DE (1) | DE60040617D1 (de) |
WO (1) | WO2001042290A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6984773B1 (en) * | 1998-01-09 | 2006-01-10 | The Salk Institute For Biological Studies | Transgenic mice expressing a human SXR receptor polypeptide |
US6548739B2 (en) * | 1999-06-18 | 2003-04-15 | City Of Hope | Method for activating peroxisome proliferator activated receptor-γ |
WO2001072837A2 (en) * | 2000-03-24 | 2001-10-04 | City Of Hope | Methods of modulating drug clearance mechanisms by altering sxr activity |
WO2003005812A2 (en) * | 2001-07-09 | 2003-01-23 | The Salk Institute For Biological Studies | Modulation of metabolism of steroids and xenobiotics |
US7586021B2 (en) * | 2005-05-11 | 2009-09-08 | Sumitomo Chemical Company, Limited | Nucleic acid construct, metabolic disordered non-human animal and use thereof |
US7785879B1 (en) | 2005-09-19 | 2010-08-31 | Schering Corporation | Pregnane X receptor compositions, crystals and uses thereof |
CN102286398B (zh) * | 2010-06-21 | 2014-06-04 | 中国科学院上海生命科学研究院 | 一种生产高活性和高纯度利福霉素sv的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4160152A (en) | 1978-12-04 | 1979-07-03 | Wightman John W | Heating unit |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
EP0659045A4 (de) * | 1993-05-18 | 1997-02-26 | Inst Nat Sante Rech Med | Gentechnologisch hergestellte mäuse, die veränderungen in den genen enthalten, welche retinoinsäure-rezeptor proteine kodieren. |
JPH11127872A (ja) * | 1997-08-11 | 1999-05-18 | Japan Tobacco Inc | 新規核内レセプター蛋白質、遺伝子及びその用途 |
SE9801148D0 (sv) | 1997-10-14 | 1998-03-31 | Pharmacia & Upjohn Ab | New receptors |
US6756491B2 (en) * | 1998-01-09 | 2004-06-29 | The Salk Institute For Biological Studies | Steroid-activated nuclear receptors and uses therefor |
US6984773B1 (en) * | 1998-01-09 | 2006-01-10 | The Salk Institute For Biological Studies | Transgenic mice expressing a human SXR receptor polypeptide |
JP2002535241A (ja) | 1998-03-27 | 2002-10-22 | グラクソ グループ リミテッド | オーファン核内受容体 |
AUPP362898A0 (en) | 1998-05-21 | 1998-06-11 | University Of Sydney, The | Xenobiotic induction of gene expression |
-
1999
- 1999-12-09 US US09/458,366 patent/US6984773B1/en not_active Expired - Lifetime
-
2000
- 2000-12-08 CA CA2394970A patent/CA2394970C/en not_active Expired - Lifetime
- 2000-12-08 DE DE60040617T patent/DE60040617D1/de not_active Expired - Lifetime
- 2000-12-08 WO PCT/US2000/033473 patent/WO2001042290A2/en active IP Right Grant
- 2000-12-08 AT AT00984144T patent/ATE412011T1/de not_active IP Right Cessation
- 2000-12-08 EP EP00984144A patent/EP1235861B1/de not_active Expired - Lifetime
- 2000-12-08 EP EP08167162A patent/EP2036925A1/de not_active Withdrawn
- 2000-12-08 AU AU20816/01A patent/AU783367B2/en not_active Ceased
- 2000-12-08 JP JP2001543587A patent/JP2003516135A/ja active Pending
-
2002
- 2002-02-20 US US10/081,555 patent/US7214482B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/495,263 patent/US7972782B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1235861B1 (de) | 2008-10-22 |
ATE412011T1 (de) | 2008-11-15 |
JP2003516135A (ja) | 2003-05-13 |
EP2036925A1 (de) | 2009-03-18 |
CA2394970C (en) | 2015-02-03 |
WO2001042290A2 (en) | 2001-06-14 |
AU2081601A (en) | 2001-06-18 |
US20030223993A1 (en) | 2003-12-04 |
US6984773B1 (en) | 2006-01-10 |
US7972782B2 (en) | 2011-07-05 |
WO2001042290A3 (en) | 2002-03-14 |
US7214482B2 (en) | 2007-05-08 |
CA2394970A1 (en) | 2001-06-14 |
EP1235861A2 (de) | 2002-09-04 |
AU783367B2 (en) | 2005-10-20 |
US20070026445A1 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69939101D1 (de) | Neue steroid-aktivierte kernrezeptoren und verwendungen dafür | |
Baraban et al. | Interneuron diversity series: interneuronal neuropeptides–endogenous regulators of neuronal excitability | |
Tejeda et al. | Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders | |
Abbas et al. | Comprehensive behavioral analysis of male Ox1r−/− mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior | |
Geyer et al. | The role of preclinical models in the development of psychotropic drugs | |
Mandillo et al. | Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study | |
McGrath et al. | Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorder | |
Smith et al. | Access to a running wheel inhibits the acquisition of cocaine self-administration | |
Parkitna et al. | Novelty-seeking behaviors and the escalation of alcohol drinking after abstinence in mice are controlled by metabotropic glutamate receptor 5 on neurons expressing dopamine d1 receptors | |
Delille et al. | The two faces of the pharmacological interaction of mGlu2 and 5-HT2A–relevance of receptor heterocomplexes and interaction through functional brain pathways | |
Blasiak et al. | Interactions of circadian rhythmicity, stress and orexigenic neuropeptide systems: implications for food intake control | |
Singh et al. | Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain | |
Marks et al. | A test battery for measuring nicotine effects in mice | |
DE60040617D1 (de) | Transgene maus, die steroid-aktivierte kernrezeptoren exprimiert | |
Sparks et al. | Opposing cholinergic and serotonergic modulation of layer 6 in prefrontal cortex | |
Halberstadt et al. | Interactive effects of mGlu5 and 5-HT 2A receptors on locomotor activity in mice | |
Olsen et al. | Loss of BDNF or its receptors in three mouse models has unpredictable consequences for anxiety and fear acquisition | |
Ikoma et al. | Inactivation of serotonergic neurons in the rostral medullary raphé attenuates stress-induced tachypnea and tachycardia in mice | |
Goldman et al. | Toward a multiscale description of microvascular flow regulation: O2-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks | |
Mu et al. | Cholinergic system in sleep regulation of emotion and motivation | |
Chung et al. | The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders | |
Costa et al. | Treadmill running frequency on anxiety and hippocampal adenosine receptors density in adult and middle-aged rats | |
Joffe et al. | GluN1 deletions in D1-and A2A-expressing cell types reveal distinct modes of behavioral regulation | |
Song et al. | Sex differences in motivated behaviors in animal models | |
Morley-Fletcher et al. | Prenatal stress affects 3, 4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |